Halozyme Therapeutics
Price & Volume
Stats
See moreOpen | $130.98 |
Previous Close | $128.62 |
Day Range | $126.89-$130.98 |
52W Range | $61.23-$134 |
Market Cap | $14.6B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $1.6B |
Revenue Growth (YoY) | 47.7% |
Gross Profit (12 Mos) | $1.2B |
Diluted EPS | $3.42 |
News
See moreYahoo Finance • 8 days ago
Strong Royalties and New Launches Accelerate Halozyme Therapeutics’ (HALO) Growth Momentum
Yahoo Finance • 12 days ago
How Halozyme, Up Nearly 90% This Year, Is Rivaling Merck And Hitting New Highs
Yahoo Finance • 12 days ago
BeOne Stock Tests Buy Zone With Visions Of 177% Earnings Growth. Watch This Clue.
Yahoo Finance • 12 days ago
How Halozyme, Up 80% This Year, Is Rivaling Merck And Hitting New Highs
About
CEO | Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. |
CFO | Mr. Darren Snellgrove |
Address | 12390 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 423 |